The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis
2017 · European Journal of Cancer · 114 citations
https://doi.org/10.1016/j.ejca.2017.07.024
M
Mara Ghilardi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
4.0K
Citations
34
h-index
57
i10-index
Mara Ghilardi is an academic researcher from Azienda Ospedaliera Treviglio. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Treatment and Pharmacology & Breast Cancer Treatment Studies. The author has an h-index of 34, co-authored 91 publications.
Papers by this author
worksUtility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort
2023 · Journal of Thrombosis and Haemostasis · 28 citations
https://doi.org/10.1016/j.jtha.2023.03.037
The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis
2023 · The Breast · 19 citations
https://doi.org/10.1016/j.breast.2023.05.002
Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?
2009 · Expert Opinion on Investigational Drugs · 14 citations
https://doi.org/10.1517/13543780903222268
Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis
2023 · Anticancer Research · 12 citations
https://doi.org/10.21873/anticanres.16625
Response of conventional chondrosarcoma to gemcitabine alone: a case report
2015 · Clinical Sarcoma Research · 9 citations
https://doi.org/10.1186/s13569-015-0025-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat